| GPMCX | TRZKX | GPMCX / TRZKX | |
| Total Expense Ratio | 2.00 | 0.00 | - |
| Annual Report Gross Expense Ratio | 1.99 | 1.06 | 188% |
| Fund Existence | 11 years | 5 years | - |
| Gain YTD | 2.254 | 9.535 | 24% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 45.5M | 6.7B | 1% |
| Annual Yield % from dividends | 1.87 | 2.49 | 75% |
| Returns for 1 year | 2.43 | 15.16 | 16% |
| Returns for 3 years | 29.02 | 46.20 | 63% |
| Returns for 5 years | -22.00 | -10.48 | 210% |
| Returns for 10 years | 60.63 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LYFCX | 18.46 | 0.47 | +2.61% |
| AlphaCentric Life Sciences & Hlthcare C | |||
| EADIX | 21.62 | 0.15 | +0.70% |
| Eaton Vance Global Equity Income A | |||
| DBORX | 25.53 | 0.03 | +0.12% |
| BNY Mellon Balanced Opportunity I | |||
| BBGSX | 18.09 | -0.20 | -1.09% |
| Bridge Builder Small/Mid Cap Growth | |||
| LADQX | 29.29 | -1.13 | -3.71% |
| Lord Abbett Developing Growth R2 | |||